Gene · 4038
Papers1,660
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,660
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Animal models of myasthenia gravis. | Int Rev Neurobiol | 2025 | 40675733 | PubTator, text mining | PubMed |
| Myasthenia gravis: Mechanisms, clinical syndromes, and diagnosis. | Dis Mon | 2025 | 40579340 | PubTator, text mining | PubMed |
| Effective use of BCMA-targeting bispecific T cell-engaging antibody in treatment-refractory LRP4+ myasthenia gravis. | Mol Ther | 2025 | 40534130 | PubTator, text mining | PubMed |
| Potential therapeutic targets for deep vein thrombosis: A proteome-wide Mendelian randomization study. | Phlebology | 2025 | 40462713 | PubTator, text mining | PubMed |
| Periplocin targets LRP4 to regulate metabolic homeostasis and anti-inflammation for the treatment of IVDD. | Phytomedicine | 2025 | 40440911 | PubTator, text mining | PubMed |
| Alterations in gene expression associated with invasion of RAS-mutant thyroid tumors and their potential diagnostic and therapeutic utility. | Eur Thyroid J | 2025 | 40440326 | PubTator, text mining | PubMed |
| SP1 promotes triple-negative breast cancer progression by targeting USP5. | Cancer Cell Int | 2025 | 40375299 | PubTator, text mining | PubMed |
| Myasthenia gravis with double-seropositive acetylcholine receptor and low-density lipoprotein receptor-related protein 4 antibodies combined with muscle atrophy: a case report and literature review. | Front Immunol | 2025 | 40356916 | PubTator, text mining | PubMed |
| Identification of characteristic genes in cutaneous squamous cell carcinoma based on weighted gene co-expression network analysis. | Front Genet | 2025 | 40296873 | PubTator, text mining | PubMed |
| Agrin/Dok-7-induced JPH2 phosphorylation in muscle cells is involved in AChR clustering. | FEBS Lett | 2025 | 40290048 | PubTator, text mining | PubMed |
| Rozanolixizumab for Myasthenia Gravis: a breakthrough treatment and future prospects. | Immunotherapy | 2025 | 40277145 | PubTator, text mining | PubMed |
| Efgartigimod improves non-AChR generalized Myasthenia Gravis: a real world experience. | Neurol Sci | 2025 | 40128464 | PubTator, text mining | PubMed |
| Development and Application of a Cell-Based Assay for Detecting Anti-Agrin Antibodies Associated With Myasthenia Gravis. | J Clin Neurol | 2025 | 40065451 | PubTator, text mining | PubMed |
| A Case of Myasthenia Gravis: A Paraneoplastic Syndrome or an Immune-Related Disorder? | Cureus | 2025 | 40062097 | PubTator, text mining | PubMed |
| Single-nuclei sequencing of skeletal muscle reveals subsynaptic-specific transcripts involved in neuromuscular junction maintenance. | Nat Commun | 2025 | 40044687 | PubTator, text mining | PubMed |
| Autoantibodies in myasthenia gravis: cluster analysis and clinical correlations. | Front Neurol | 2025 | 39968461 | PubTator, text mining | PubMed |
| Transcriptomic characterization of postnatal muscle maturation. | Dis Model Mech | 2025 | 39945189 | PubTator, text mining | PubMed |
| LRP4 and Agrin Are Modulated by Cartilage Degeneration and Involved in β-Catenin Signaling in Human Articular Chondrocytes. | Int J Mol Sci | 2025 | 39940775 | PubTator, text mining | PubMed |
| Identifying rare variants in genes related to bone phenotypes in a cohort of postmenopausal women. | Osteoporos Int | 2025 | 39915337 | PubTator, text mining | PubMed |
| MuSK Regulates Neuromuscular Junction Nav1.4 Localization and Excitability. | J Neurosci | 2025 | 39880682 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4038/papers?page=5